Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Depreciation & Amortization (CF) (2012 - 2026)

Precigen (PGEN) posted quarterly Depreciation & Amortization (CF) of $1.1 million for Q1 2026, up 74.72% year-over-year from $629000.0 in Q1 2025, and down 3.34% quarter-over-quarter from $1.1 million in Q4 2025.

Analysis

Precigen (PGEN) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Depreciation & Amortization (CF) for 15 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) rose 74.72% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $3.7 million (up 3.06% YoY), while the FY2025 annual figure was $3.2 million, down 29.32% from the prior year.
  • Depreciation & Amortization (CF) declined to $1.1 million in Q1 2026 per PGEN's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $3.3 million in Q1 2022 and bottomed at $629000.0 in Q1 2025.
  • Historically, Depreciation & Amortization (CF) has averaged $1.4 million across 5 years, with a median of $1.6 million in 2024.
  • Annual changes were most pronounced in 2025 — Depreciation & Amortization (CF) sank 60.56% — and 2026, when it surged 74.72%.
  • Precigen's Depreciation & Amortization (CF) stood at $1.7 million in 2022, then fell by 6.22% to $1.6 million in 2023, then tumbled by 59.05% to $661000.0 in 2024, then soared by 72.01% to $1.1 million in 2025, then slipped by 3.34% to $1.1 million in 2026.
  • Business Quant data shows PGEN's Depreciation & Amortization (CF) at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $803000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn 1.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Mn
Mar 31, 2026 1.10 Mn
Dec 31, 2025 1.14 Mn
Sep 30, 2025 803,000.00
Jun 30, 2025 630,000.00
Mar 31, 2025 629,000.00
Dec 31, 2024 661,000.00
Sep 30, 2024 674,000.00
Jun 30, 2024 1.60 Mn
Mar 31, 2024 1.60 Mn
Dec 31, 2023 1.61 Mn
Sep 30, 2023 1.65 Mn
Jun 30, 2023 1.69 Mn
Mar 31, 2023 1.71 Mn
Dec 31, 2022 1.72 Mn
Sep 30, 2022 1.72 Mn
Jun 30, 2022 1.84 Mn
Mar 31, 2022 3.29 Mn
Dec 31, 2021 3.32 Mn
Sep 30, 2021 2.03 Mn